| Kelvin C Harris, MD | |
|
2680 Aberdeen Blvd, Suite A, Gastonia, NC 28054-0637 | |
| (704) 865-2229 | |
| (704) 865-2811 |
| Full Name | Kelvin C Harris |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 2680 Aberdeen Blvd, Gastonia, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114000791 | NPI | - | NPPES |
| 8939948 | Medicaid | NC | |
| N38774 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 38774 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caromont Regional Medical Center | Gastonia, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Caromont Medical Group Inc | 3577476258 | 328 |
News Archive
With an election on the horizon, and Canadian pharmacies proving to be as safe as U.S. counterparts, the Food and Drug Administration and big pharma are increasing efforts to prevent Canadian drug importation.
A new systematic review suggests that a certain kind of vaccine may help to protect babies and small children from a devastating killer: meningococcal meningitis.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL).
In the meantime, Minnesota's hospitals saw their uncompensated care costs increase at the slowest rate in five years.
The first patient was successfully treated by the state-of-the-art technology in radiotherapy - linear accelerator, which began functioning last week at RR Cancer Institute and Research Centre, Sri Ram Murti Smarak Institute of Medical Sciences (SRMSIMS), Bareilly in India.
› Verified 6 days ago
| Entity Name | Caromont Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356314272 PECOS PAC ID: 3577476258 Enrollment ID: O20031201000070 |
News Archive
With an election on the horizon, and Canadian pharmacies proving to be as safe as U.S. counterparts, the Food and Drug Administration and big pharma are increasing efforts to prevent Canadian drug importation.
A new systematic review suggests that a certain kind of vaccine may help to protect babies and small children from a devastating killer: meningococcal meningitis.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL).
In the meantime, Minnesota's hospitals saw their uncompensated care costs increase at the slowest rate in five years.
The first patient was successfully treated by the state-of-the-art technology in radiotherapy - linear accelerator, which began functioning last week at RR Cancer Institute and Research Centre, Sri Ram Murti Smarak Institute of Medical Sciences (SRMSIMS), Bareilly in India.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelvin C Harris, MD 2680 Aberdeen Blvd, Suite A, Gastonia, NC 28054-0637 Ph: (704) 865-2229 | Kelvin C Harris, MD 2680 Aberdeen Blvd, Suite A, Gastonia, NC 28054-0637 Ph: (704) 865-2229 |
News Archive
With an election on the horizon, and Canadian pharmacies proving to be as safe as U.S. counterparts, the Food and Drug Administration and big pharma are increasing efforts to prevent Canadian drug importation.
A new systematic review suggests that a certain kind of vaccine may help to protect babies and small children from a devastating killer: meningococcal meningitis.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL).
In the meantime, Minnesota's hospitals saw their uncompensated care costs increase at the slowest rate in five years.
The first patient was successfully treated by the state-of-the-art technology in radiotherapy - linear accelerator, which began functioning last week at RR Cancer Institute and Research Centre, Sri Ram Murti Smarak Institute of Medical Sciences (SRMSIMS), Bareilly in India.
› Verified 6 days ago
Dr. Irvin R Bonnin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 991 W Hudson Blvd, Gastonia, NC 28052 Phone: 704-853-5000 Fax: 704-862-6194 | |
Dr. Erica Cunill, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 991 W Hudson Blvd, Gastonia, NC 28052 Phone: 704-853-5000 Fax: 704-862-5353 | |
Tamara Allen Means, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 620 Summit Crossing Pl Ste 108a, Gastonia, NC 28054 Phone: 704-865-2229 Fax: 704-865-2811 | |
Cara Scott, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 706 Summit Crossing Pl, Gastonia, NC 28054 Phone: 704-854-3600 | |
Cortney Raye Booth, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 620 Summit Crossing Pl Ste 108a, Gastonia, NC 28054 Phone: 704-671-5313 | |
Dr. Chanel Bonds Roper, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1225 E Garrison Blvd, Gastonia, NC 28054 Phone: 704-671-5343 |